In the present study, the incorporated non-natural amino acids into the sequence of WT1 peptides allowed us to determine if these alterations would increase avidity of binding to MHC, improve immunogenicity and result in cross-reactivity and cytolytic activity against WT1 expressing cancer cells, and study the MHC-peptide complex. Here, HLA-C is linked to cancer.